Thursday, March 18, 2010 Last update: 3:30 AM

State-by-State AND City-by-City FreshNews.com Delivers Company Tech News

Cadence Pharmaceuticals

print this company - email to a friend - join our eNewsletter

Website:

http://www.cadencepharm.com

News articles for Cadence Pharmaceuticals:

Tuesday, February 10, 2009

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference

Posted at 02/10/2009 - 5:28pm

Thursday, February 5, 2009

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the BIO CEO and Investor Conference in New York City

Posted at 02/05/2009 - 10:17am

Wednesday, December 17, 2008

Cadence Pharmaceuticals Announces Positive Topline Results of Phase III Clinical Trial of Acetavance in Laparoscopic Surgery

Posted at 12/17/2008 - 2:52pm

Wednesday, October 22, 2008

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the BIOCOM Investor Conference

Posted at 10/22/2008 - 5:05am

Monday, September 29, 2008

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference

Posted at 09/29/2008 - 4:46pm

Tuesday, September 16, 2008

Cadence Pharmaceuticals Updates Omigard Clinical Timeline

Posted at 09/16/2008 - 8:03am

Friday, September 5, 2008

VAN NUYS--- Microfabrica Secures $22.5 Million Funding to Grow Its Medical Device Business

Posted at 09/05/2008 - 7:44am

Friday, August 29, 2008

SAN DIEGO--- Cadence Pharmaceuticals Appoints Todd Rich, M.D. to its Board of Directors and Names Malcolm Lloyd-Smith as Senior

Posted at 08/29/2008 - 8:35am

Thursday, August 28, 2008

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the 2008 NewsMakers In the Biotech Industry Conference

Posted at 08/28/2008 - 3:14pm

Monday, August 4, 2008

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at Two Investment Conferences During the Month of August 2008

Posted at 08/04/2008 - 3:30pm

Friday, August 1, 2008

MENLO PARK--- Versant Ventures Announces Closing of $500 Million Venture Fund

Posted at 08/01/2008 - 5:13pm

Wednesday, July 30, 2008

Cadence Pharmaceuticals Announces FDA Concurrence With Clinical Development Plan for Acetavance

Posted at 07/30/2008 - 5:22pm

Wednesday, June 4, 2008

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medica

Posted at 06/04/2008 - 6:16pm

Wednesday, April 30, 2008

Cadence Pharmaceuticals' CEO Ted Schroeder to Present at Three Investment Conferences During the Month of May

Posted at 04/30/2008 - 5:02pm

Wednesday, February 20, 2008

SAN DIEGO--- Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering

Posted at 02/20/2008 - 5:03pm

Friday, February 15, 2008

SAN DIEGO--- Cadence Pharmaceuticals to Raise up to $49.3 Million in Registered Direct Common Stock Offering

Posted at 02/15/2008 - 9:46am

Friday, January 11, 2008

Cadence Pharmaceuticals Announces Topline Results of Two Phase III Clinical Trials of Acetavance

Posted at 01/11/2008 - 9:32am

Wednesday, October 17, 2007

Omiganan Phase II Rosacea Study Demonstrates Promising Results

Posted at 10/17/2007 - 3:40pm

Wednesday, October 3, 2007

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at BIO Investor Forum

Posted at 10/03/2007 - 6:00pm

Thursday, September 20, 2007

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at UBS 2007 Global Life Sciences Conference

Posted at 09/20/2007 - 8:03am

Add new comment

Biotech/Biomedical/Health